Announcements
- Lifecore Biomedical Completes Incremental Liquidity Initiatives
- Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
- Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
- Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
- Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
- Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
- Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
- Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
- Lifecore Biomedical Provides Business Update
- Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.15 |
---|---|
High | 5.20 |
Low | 5.15 |
Bid | 5.10 |
Offer | 5.35 |
Previous close | 5.35 |
Average volume | 0.00 |
---|---|
Shares outstanding | 30.55m |
Free float | 29.16m |
P/E (TTM) | -- |
Market cap | 176.26m USD |
EPS (TTM) | -2.12 USD |
Data delayed at least 15 minutes, as of May 17 2024 15:31 BST.
More ▼